<DOC>
	<DOCNO>NCT00859300</DOCNO>
	<brief_summary>We propose comparative case-control study 2 follow group patient : - Cases : 500 patient ventricular fibrillation acute phase myocardial infarct , - Controls : 500 patient without ventricular fibrillation acute phase myocardial infarct . The primary endpoint study correlation phenotype/genotype sudden death acute phase myocardial infarct . The first phase study , include patient ' recruitment , clinical biological data collection , last 82 month . The second phase concern genotype/phenotype analysis identification polymorphisms associate sudden death risk myocardial infarction . This study allow good knowledge mechanism sudden death identification new risk marker .</brief_summary>
	<brief_title>MAP-IDM : Identification Molecular Markers Sudden Death Acute Phase Myocardial Infarction</brief_title>
	<detailed_description>The number sudden death estimate around 50000 France . In case , death due myocardial infarction . This complication occur , 70 % case , patient 's residence , within 30 minute follow thoracic pain . Emergency care often come late allows 2 % patient heart failure revitalize . At equal sex , age clinical status , patient may develop ventricular rhythm disorder . Then , notion risk background genetic disposition investigate . No prospective study conduct sufficient number patient yet . Such study recent development new genetic technology help identify marker sudden death risk acute phase myocardial infarction . The study implement increase knowledge sudden death mechanism acute phase myocardial infarction . The analysis phenotypic/genotypic relation lead identification new risk marker . Further evaluations new diagnostic therapeutic strategy possible basis trial . Ventricular fibrillation acute phase myocardial infarction follow polygenic determinism . The gene involve electrical trouble lead expression potassic , calcic sodic channel ventricular myocytes : KCNQ1 , KCNH2 , SCN5A , KCNE1 , KCNE2 , KCNJ2 , PRKAG2 , RyR2 , PKP2 , DSP , CASQ2 , CACNA1C , FKBP1B . An association favourable genetic background ischemia represent cause ventricular arrhythmia complication myocardial infarction . Haplotypes gene consider new marker sudden death risk ischemic origin search .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Death , Sudden</mesh_term>
	<criteria>All patient admit ICU MI present follow criterion : Age &gt; 18 Group 1 ( Case ) Patients cardiac arrest ventricular fibrillation develop 24 h post MI Group 2 ( control ) Patients MI ( ventricular fibrillation ) Written informed consent . No write informed consent Known Medical History cardiomyopathy , include acute coronary syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>ventricular fibrillation</keyword>
	<keyword>sudden death</keyword>
	<keyword>polymorphism</keyword>
</DOC>